Progress in the prevention of surgical site infection

Current Opinion in Infectious Diseases

Volumn 22, Issue 4, 2009, Pages 370-375

  Casey, Anna L ^a   Elliott, Tom S J ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Guidelines; Preventive strategies; Surgical site infection

Indexed keywords

ANTIBIOTIC AGENT; PSEUDOMONIC ACID; SEALANT;

BACTERIAL COLONIZATION; CLOSTRIDIUM DIFFICILE; HEALTH SERVICE; HOMEOSTASIS; HUMAN; PRACTICE GUIDELINE; PROPHYLAXIS; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION; SURGICAL SITE INFECTION;

ANTI-INFECTIVE AGENTS, LOCAL; CROSS INFECTION; HUMANS; INFECTION CONTROL; SURGICAL WOUND INFECTION;

EID: 67651087448     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e32832c4048     Document Type: Review

References (33)

1. Smyth ETM, Mcllvenny G, Enstone JE, et al. Four country prevalence survey 2006: overview of the results. J Hosp Infect 2008; 69:230-248. This paper presents an overview of a HCAI prevalence study in England, Wales, Northern Ireland and the Republic of Ireland. Procedure-specific data are given for SSI.
2. Astagneau P, Rioux C, Golliot F, et al. Morbidity and mortality associated with surgical site infections: results from the 1997-1999 INCISO surveillance. J Hosp Infect 2001; 48:267-274.
3. Coello R, Charlett A, Wilson J, et al. Adverse impact of surgical site infections in English Hospitals. J Hosp Infect 2005; 60:93-103.
4. Whitehouse JD, Friedman ND, Kirkland KB, et al. The impact of surgical-site infections following orthopaedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 2002; 23:183-189.
5. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for the prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999; 20:250-278.
6. Yokoe DS, Mermel LA, Anderson DJ, et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29 (Suppl 1):S12-S21.
7. Anderson DJ, Kaye KS, Classen D, et al. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29 (Suppl 1):S51-S61. This article highlights a set of basic strategies to prevent SSI. The strategies are taken from a range of recommendations, guidelines and requirements, which exist in the United States.
8. National Institute for Health and Clinical Excellence. Surgical Site Infection. October 2008 (Clinical guideline 74.) www.nice.org.uk/Guidance/CG74. These clinical guidelines provide healthcare professionals working in England, Wales and Northern Ireland with a set of strategies to prevent SSI.
9. National Institute for Health and Clinical Excellence. Perioperative hypothermia (inadvertent). April 2008 (Clinical guideline 65.) www.nice.org.uk/Guidance/CG65. This set of guidelines covers the care and treatment of patients who are having surgery in the National Health Service in England and Wales. Strategies to reduce the risk of pre, peri or postoperative hypothermia are outlined.
10. Krukowski ZH, Bruce J. Commentary: controversies in NICE guidance on surgical site infection. BMJ 2008; 337:a2120.
11. Mahaffey PJ. Surgical site infection. Guidelines or misguidance? BMJ 2008; 337:a2578.
12. Tanner J, Swarbrook S, Stuart J. Surgical hand antisepsis to reduce surgical site infection. Cochrane Database Syst Rev 2008; 1:CD004288. This systematic review summarizes research into the different antiseptics used for surgical hand antisepsis and their effect on rates of SSI and numbers of micro-organisms on the skin.
13. Munoz P, Hortal J, Giannella M, et al. Nasal carriage of S. aureus increases the risk of surgical site infection after major heart surgery. J Hosp Infect 2008; 68:25-31. In this observational study, nasal carriage of S. aureus was demonstrated to be a risk factor for SSI following major cardiac surgery.
14. Wertheim HF, Melles DC, Vos MC, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005; 5:751-762.
15. van Rijen MM, Bonten M, Wenzel RP, Kluytmans JA. Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review. J Antimicrob Chemother 2008; 61:254-261. This review outlines meta-analyses of studies assessing the effect of intranasal mupirocin on infection rate in surgical patients who are S. aureus carriers. This review demonstrated that the intranasal use of mupirocin reduced the overall incidence of S. aureus infection in these patients.
16. Hacek DM, Robb WJ, Paule SM, et al. Staphylococcus aureus nasal decolonization in joint replacement surgery reduces infection. Clin Orthop Relat Res 2008; 466:1349-1355.
17. Rao N, Cannella B, Crossett LS, et al. A preoperative decolonization protocol for Staphylococcus aureus prevents orthopaedic infections. Clin Orthop Relat Res 2008; 466:1343-1348.
18. Coia JE, Duckworth GJ, Edwards DI, et al., Joint Working Party of the British Society of Antimicrobial Chemotherapy; Hospital Infection Society; Infection Control Nurses Association. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 2006; 63 (Suppl 1):S1-S44.
19. Towfigh S, Cheadle WG, Lowry SF, et al. Significant reduction in incidence of wound contamination by skin flora through use of microbial sealant. Arch Surg 2008; 143:885-891. In this randomized clinical trial, patients were randomized to receive standard preoperative skin preparation alone or with application of a cyanoacrylate-based liquid microbial sealant. The level of wound contamination was assessed during surgery. Patients who received the sealant were more likely to have bacteria recovered from the wound (47 vs. 31%, P = 0.04).
20. Meyhoff CS, Wetterslev J, Jorgensen LN, et al. Perioperative oxygen fraction - effect on surgical site infection and pulmonary complications after abdominal surgery: a randomized clinical trial. Rationale and design of the PROXI-Trial. Trials 2008; 9:58. This paper provides a meta-analysis of studies determining the effect of supplementary perioperative oxygen on rates of SSI. Furthermore, the authors outline the design of their current clinical trial assessing this potential risk factor for SSI.
21. Gardella C, Goltra LB, Laschansky E, et al. High-concentration supplemental perioperative oxygen to reduce the incidence of postcesarean surgical site infection: a randomized controlled trial. Obstet Gynecol 2008; 112:545-552.
22. Wright TI, Baddour LM, Berbari EF, et al. Antibiotic prophylaxis in dermatologic surgery: advisory statement 2008. J Am Acad Dermatol 2008; 59:464-473. This advisory statement on the use of antibiotic prophylaxis in dermatologic surgery recommends that antimicrobial prophylaxis is not routinely required for dermatologic surgery; however, it should be considered when surgery is undertaken in the lower extremities and the groin, during wedge excisions of the lip or ear, skin flaps on the nose and during skin grafting.
23. Maragh SL, Brown MD. Prospective evaluation of surgical site infection rate among patients with Mohs micrographic surgery without the use of prophylactic antibiotics. J Am Acad Dermatol 2008; 59:275-278.
24. Hawn MT, Itani KM, Gray SH, et al. Association of timely administration of prophylactic antibiotics for major surgical procedures and surgical site infection. J Am Coll Surg 2008; 206:814-819; discussion 819-21. This retrospective cohort analysis, which included patients from a range of surgical specialities, demonstrated that untimely prophylactic antibiotic administration did not markedly contribute to SSI rates.
25. Milstone AM, Maragakis LL, Townsend T, et al. Timing of preoperative antibiotic prophylaxis: a modifiable risk factor for deep surgical site infections after pediatric spinal fusion. Pediatr Infect Dis J 2008; 27:704-708. This case-control study involving patients undergoing spinal fusion demonstrated that inappropriate timing of preoperative antibiotic prophylaxis administration was a significant independent risk factor for deep SSI.
26. Olsen MA, Nepple JJ, Riew KD, et al. Risk factors for surgical site infection following orthopaedic spinal operations. J Bone Joint Surg Am 2008; 90:62-69.
27. Mannien J, van den Hof S, Muilwijk J, et al. Trends in the incidence of surgical site infection in the Netherlands. Infect Control Hosp Epidemiol 2008; 29:1132-1138. This paper outlines a trend towards reduction in rates of SSI in the Netherlands. The surveillance was undertaken in the PREZIES network over a 10-year period.
28. Gastmeier P, Sohr D, Schwab F, et al. Ten years of KISS: the most important requirements for success. J Hosp Infect 2008; 70 (Suppl 1):11-16. This review article describes the success of 10 years of the KISS surveillance network in Germany. The article gives an overview of elements crucial to the success of the network in addition to an overview of reductions in HCAI.
29. Vincent A, Ayzac L, Girard R, et al. Downward trends in surgical site and urinary tract infections after cesarean delivery in a French surveillance network. Infect Control Hosp Epidemiol 2008; 29:227-233. This paper outlines a trend towards reduction in rates of SSI following caesarean section. The surveillance was undertaken in the Mater Sud-Est surveillance network over a 7-year period in France.
30. Trussell J, Gerkin R, Coates B, et al. Impact of a patient care pathway protocol on surgical site infection rates in cardiothoracic surgery patients. Am J Surg 2008; 196:883-889; discussion 889. In a retrospective evaluation, a quality care initiative, including peri-incisional antibiotic administration, close blood glucose control and hair removal with clippers was implemented. The rate of SSI was significantly lower in the experimental group compared with the controls.
31. Forbes SS, Stephen WJ, Harper WL, et al. Implementation of evidence-based practices for surgical site infection prophylaxis: results of a pre and post-intervention study. J Am Coll Surg 2008; 207:336-341.
32. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascularcatheter-relatedinfections. MMWR Recomm Rep 2002;51:1-29.
33. Pratt RJ, Pellowe CM, Wilson JA, et al. Epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 2007; 65 (Suppl 1):S1-64.